
Madrigal Pharmaceuticals MDGL
$ 512.51
-4.0%
Annual report 2025
added 02-19-2026
Madrigal Pharmaceuticals Total Inventories 2011-2026 | MDGL
Annual Total Inventories Madrigal Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 74.8 M | 34.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 74.8 M | 34.1 M | 54.5 M |
Quarterly Total Inventories Madrigal Pharmaceuticals
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69.3 M | 63.5 M | 55.2 M | 34.1 M | 8.72 M | 7.07 M | 854 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 69.3 M | 854 K | 34.1 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.38 | -1.08 % | $ 367 M | ||
|
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | ||
|
Aytu BioScience
AYTU
|
11.4 M | $ 2.57 | -3.48 % | $ 16.1 M | ||
|
Gilead Sciences
GILD
|
1.77 B | $ 138.79 | -0.96 % | $ 173 B | ||
|
GT Biopharma
GTBP
|
42 K | $ 0.41 | -7.26 % | $ 2.26 M | ||
|
Halozyme Therapeutics
HALO
|
176 M | $ 63.49 | 0.64 % | $ 7.61 B | ||
|
Coherus BioSciences
CHRS
|
3.17 M | $ 1.62 | -3.1 % | $ 190 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
82.7 M | $ 318.56 | -3.57 % | $ 41.7 B | ||
|
Harmony Biosciences Holdings
HRMY
|
5.36 M | $ 27.62 | -0.34 % | $ 1.59 B | ||
|
iBio
IBIO
|
3.9 M | $ 2.08 | 2.47 % | $ 21.8 M | ||
|
ImmuCell Corporation
ICCC
|
9.27 M | $ 6.54 | -1.06 % | $ 59 M |